|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0003015,
umls-concept:C0003364,
umls-concept:C0006684,
umls-concept:C0008976,
umls-concept:C0012798,
umls-concept:C0022646,
umls-concept:C0027051,
umls-concept:C0030705,
umls-concept:C0087111,
umls-concept:C0332293,
umls-concept:C0684224,
umls-concept:C0857121,
umls-concept:C1274040
|
|
pubmed:issue |
8
|
|
pubmed:dateCreated |
2005-4-26
|
|
pubmed:abstractText |
This study was performed to determine whether, in high-risk hypertensive patients with a reduced glomerular filtration rate (GFR), treatment with a calcium channel blocker or an angiotensin-converting enzyme inhibitor lowers the incidence of renal disease outcomes compared with treatment with a diuretic.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Apr
|
|
pubmed:issn |
0003-9926
|
|
pubmed:author |
pubmed-author:BarzilayJoshuaJ,
pubmed-author:BatumanVecihiV,
pubmed-author:DavisBarry RBR,
pubmed-author:EckfeldtJohn HJH,
pubmed-author:FarberMichaelM,
pubmed-author:HenriquezMarioM,
pubmed-author:KopytNelsonN,
pubmed-author:LouisGail TGT,
pubmed-author:NwachukuChukeC,
pubmed-author:PresselSaraS,
pubmed-author:RahmanMahboobM,
pubmed-author:SaklayenMohammadM,
pubmed-author:StanfordCarolC,
pubmed-author:WalworthCandaceC,
pubmed-author:WardHarryH,
pubmed-author:WheltonPaul KPK,
pubmed-author:WiegmannThomasT,
pubmed-author:WrightJackson TJTJr
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
25
|
|
pubmed:volume |
165
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
936-46
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:15851647-Aged,
pubmed-meshheading:15851647-Amlodipine,
pubmed-meshheading:15851647-Angiotensin-Converting Enzyme Inhibitors,
pubmed-meshheading:15851647-Blood Pressure,
pubmed-meshheading:15851647-Calcium Channel Blockers,
pubmed-meshheading:15851647-Chlorthalidone,
pubmed-meshheading:15851647-Coronary Disease,
pubmed-meshheading:15851647-Diuretics,
pubmed-meshheading:15851647-Double-Blind Method,
pubmed-meshheading:15851647-Female,
pubmed-meshheading:15851647-Follow-Up Studies,
pubmed-meshheading:15851647-Glomerular Filtration Rate,
pubmed-meshheading:15851647-Humans,
pubmed-meshheading:15851647-Hypertension,
pubmed-meshheading:15851647-Incidence,
pubmed-meshheading:15851647-Kidney Failure, Chronic,
pubmed-meshheading:15851647-Lisinopril,
pubmed-meshheading:15851647-Male,
pubmed-meshheading:15851647-Middle Aged,
pubmed-meshheading:15851647-Patient Compliance,
pubmed-meshheading:15851647-Risk Factors,
pubmed-meshheading:15851647-Treatment Outcome
|
|
pubmed:year |
2005
|
|
pubmed:articleTitle |
Renal outcomes in high-risk hypertensive patients treated with an angiotensin-converting enzyme inhibitor or a calcium channel blocker vs a diuretic: a report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).
|
|
pubmed:affiliation |
Division of Nephrology and Hypertension, Case Western Reserve University, University Hospitals of Cleveland, Cleveland Veterans Affairs Medical Center, Cleveland, Ohio, USA.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Comparative Study,
Research Support, U.S. Gov't, P.H.S.,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't
|
